Time to first decision:
1 days*
Time to first decision with review:
44 days*
Acceptance to publication:
22 days*
Impact Factor:
Total content views:
Total Altmetric mentions:

Aims and scope

BMJ Evidence-Based Medicine aims to:
  • Publish research, insights and opinions on what matters for health care
  • Focus on the tools, methods, and concepts that are basic and central to teaching and practising evidence-based medicine (EBM).
We deliver relevant, trustworthy and impactful evidence by:
  • Publishing relevant research from primary studies and evidence syntheses on topics in general medicine
  • Disseminating important tools for teaching and implementing EBM in clinical practice
  • Providing perspective, debate, analysis, and opinion on trusted evidence and relevant topics in EBM
For information about the Editor-in-Chief and editorial team, please refer to the Editorial Board page.

Transitioning to a greener future

BMJ Evidence-Based Medicine now publishes solely online. This change brings significant climate and environmental benefits. Transitioning to online-only means we can completely eliminate the substantial use of energy, water and chemicals that is involved in the complex production and distribution process of a print journal. Most of our readers already use our website ebm.bmj.com for most of their needs–the website after all offers readers a far richer experience with more content overall. We hope that this change does not cause too much inconvenience for our readers as we move towards a greener future for BMJ Evidence-Based Medicine.

Plan S compliance

BMJ Evidence-Based Medicine is a Plan S compliant Transformative Journal. Transformative Journals are one of the compliance routes offered by cOAlition S funders, such as Wellcome, WHO and UKRI. Find out more about Transformative Journals and  Plan S compliance on our Author Hub.

Journal information

BMJ Evidence-Based Medicine is owned by BMJ
Publication Model
Subscription; with hybrid open access option
Launch date
Digital Archives
Indexed by
Web of Science Core Collection: Science Citation Index Expanded, Emerging Sources Citation Index, MEDLINE (Index Medicus), PubMed Central (BMJ Open Access Special Collection), Scopus, Embase (Excerpta Medica), Google Scholar
Peer review model
Single anonymised; the names of reviewers are hidden from the author
Print ISSN
Online ISSN

Journal Statistics 2022

Acceptance rate: 22%
Speed Time to first decision without review (median): 1 days Time to first decision with review (median): 44 days Time from acceptance to publication (median): 22 days
Impact Impact Factor Category: Medicine, General & Internal Impact Factor (JCR): 5.8 Impact Factor rank: 34/167 5 Year Impact Factor: 7.5 Journal Citation Indicator: 1.1 Eigenfactor: 0.00447 Citescore: 7.4 Citescore rank: 83/830 SciMago Journal rank: 1.344
Reach Total content views: 471,970 Total Altmetric mentions: 6,270
The impact that academic research has cannot be defined by one single metric. In 2013, BMJ signed the San Francisco Declaration on Research Assessment (DORA). We did this to show our support for using multiple measures and metrics to portray journals’ impact; moving away from the Impact Factor as a single measure. How we get these metrics

Contact information

For all contact information please refer to the Contact Us page.


BMJ is a founding member of COPE (the Committee on Publication Ethics), which provides a forum for publishers and Editors of scientific journals to discuss issues relating to the integrity of the work submitted to or published in their journals. BMJ also follows guidelines on editorial independence produced by the World Association of Medical Editors (WAME) and the International Committee of Medical Journal Editors (ICMJE)
Equator Network Logo
The EQUATOR Network is an international initiative that seeks to improve the value of medical research literature by promoting transparent, accurate reporting of research studies. BMJ is a sponsor of its activities.
AllTrials Logo
BMJ is a founding organisation of the AllTrials initiative, which calls for all past and present clinical trials to be registered and their results reported.